Diminishing market access has become one of the central challenges for the pharmaceutical industry. Whereas regulatory agency approval used to be the final hurdle in drug development, now pharmaceutical companies must negotiate an obstacle course of reimbursement dossiers, cost-effectiveness studies, decentralized health authorities, and post-launch observational research…
Lees meer..

Understanding & implementing best practice approaches to value-based sales in the competitive cancer marketplace Conference dates: 15th-16th March, 2010 Venue: Brussels, Belgium This will be the only event looking at “best practice” approaches to selling and marketing high-value cancer drugs, and working in partnership with generalists and specialists such as oncologists, …
Lees meer..

Develop and implement your tactics to enhance the performance of your site pool to ensure the time, cost and quality objectives of your global trial. Conference dates: 17th-18th March, 2010 Venue: Radisson Royal, Brussels, Belgium This event will look at the principal factors that affect the performance of clinical sites when conducting trials…
Lees meer..

UCB announced that it plans to accelerate its U.S. transition to a purely specialty-focused biopharmaceutical company and will exit the primary care market in the U.S., effective 1 March 2010. This strategic decision impacts the reported 2009 net profit with one-time restructuring charges, while freeing more resources for core products…
Lees meer..

Recent crackdown on pharmaceutical companies suggests that drug marketing remains an issue with federal authorities. The Wall Street Journal reports: “Novartis AG’s agreement to settle criminal allegations involving marketing of an epilepsy drug is the latest in a string of cases showing that improper marketing practices are still a problem years after the U.S…
Lees meer..

To further protect the safety of patients taking individually prepared medications, the U.S. Pharmacopeial Convention (USP) has developed new and revised quality guidelines for pharmacists who compound - or individually prepare - these life-saving drugs…
Lees meer..

Romark Laboratories has begun enrollment of patients in a clinical trial of a drug to treat flu.

Lees meer..

Stem Cell Therapy International Inc. completed its merger with Histostem Ltd of South Korea.

Lees meer..

Missouri regulators have moved to shut down more than a dozen companies that promise health plans but have allegedly left consumers with thousands of dollars in unpaid medical bills.

Lees meer..

In his final State of the State address tonight, Gov. Phil Bredesen asked lawmakers to dip into reserves to the tune of $202 million over two years to soften the blow of budget cuts and save state jobs.

Lees meer..